Author

M. Linnerbauer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Gessner· 1 shared A. Haghikia· 1 shared A. Plasencia· 1 shared A. Sokolovska· 1 shared C. A. Akdis· 1 shared C. Clish· 1 shared C. Faust Akl· 1 shared C. Gutierrez-Vazquez· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Gessner

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Gut-specific H3R signaling orchestrates microglia-dependent resolution of peripheral inflammation

K. Duerholz, M. Linnerbauer, E. Schmid, H. Danzer, L. Loesslein, L. Amend, L. Ehnes, M. Frech, V. Azizov, F. Schaelter, A. Gessner, S. Lucas, T.-R. Lesker, R. V. Taudte, J. Hofmann, , M. M. Zaiss

The paper identifies gut microbiota-derived histamine as a factor enabling the CNS to suppress peripheral inflammation in RA by activating H3R in the intestine and modulating microglia.

bioRxiv · Jul 11, 2024 · PreprintImmunology

Engineered probiotics limit CNS autoimmunity by stabilizing HIF-1α in dendritic cells

L. M. Sanmarco, J. M. Rone, C. M. Polonio, F. Giovannoni, G. Fernandez Lahore, K. Ferrara, C. Gutierrez-Vazquez, N. Li, A. Sokolovska, A. Plasencia, C. Faust Akl, P. Nanda, E. S. Heck, Z. Li, H.-G. Lee, , F. J. Quintana

The paper identifies an immunometabolic pathway in dendritic cells that limits autoimmunity and develops a synthetic probiotic to activate this pathway.

bioRxiv · Mar 17, 2023 · PreprintImmunology